-
1
-
-
0028932216
-
Atrial natriuretic hormones originating from the N-terminus of the atrial natriuretic factor prohormone
-
Vesely DL. Atrial natriuretic hormones originating from the N-terminus of the atrial natriuretic factor prohormone. Clin Exp Pharmacol Physiol. 1995;22:108-114.
-
(1995)
Clin Exp Pharmacol Physiol
, vol.22
, pp. 108-114
-
-
Vesely, D.L.1
-
2
-
-
0028359997
-
Localization and mechanism of secretion of B type natriuretic peptide in comparison with those of A type natriuretic peptide in normal subjects and those with heart failure
-
Yasue H, Yoshimura M, Sunida H, et al. Localization and mechanism of secretion of B type natriuretic peptide in comparison with those of A type natriuretic peptide in normal subjects and those with heart failure. Circulation. 1994;90:195-203.
-
(1994)
Circulation
, vol.90
, pp. 195-203
-
-
Yasue, H.1
Yoshimura, M.2
Sunida, H.3
-
3
-
-
0025015089
-
Isolation and sequence determination of human brain natriuretic peptide in human atrium
-
Kambayashi Y, Nakao K, Mukoyama M, et al. Isolation and sequence determination of human brain natriuretic peptide in human atrium. FEBS Lett. 1990;259:341-345.
-
(1990)
FEBS Lett
, vol.259
, pp. 341-345
-
-
Kambayashi, Y.1
Nakao, K.2
Mukoyama, M.3
-
4
-
-
0024542840
-
Cloning and sequence analysis of cDNA encoding a precursor for human brain natriuretic peptide
-
Sudoh T, Maekawa K, Kojima M, et al. Cloning and sequence analysis of cDNA encoding a precursor for human brain natriuretic peptide. Biochem Biophys Res Commun. 1989;159:1427-1434.
-
(1989)
Biochem Biophys Res Commun
, vol.159
, pp. 1427-1434
-
-
Sudoh, T.1
Maekawa, K.2
Kojima, M.3
-
5
-
-
0027514661
-
Renal, endocrine, and hemodynamic effects of human brain natriuretic peptide in normal man
-
Holmes SJ, Espiner EA, Richards AM, et al. Renal, endocrine, and hemodynamic effects of human brain natriuretic peptide in normal man. J Clin Endocrinol Metab. 1993;76:91-96.
-
(1993)
J Clin Endocrinol Metab
, vol.76
, pp. 91-96
-
-
Holmes, S.J.1
Espiner, E.A.2
Richards, A.M.3
-
6
-
-
0028788981
-
The amino-terminal portion of pro-brain natriuretic peptide (Pro-bnp) circulates in human plasma
-
Hunt PJ, Yandle TG, Nicholls MG, et al. The amino-terminal portion of pro-brain natriuretic peptide (Pro-bnp) circulates in human plasma. Biochem Biophys Res Commun. 1995;214:1175-1183.
-
(1995)
Biochem Biophys Res Commun
, vol.214
, pp. 1175-1183
-
-
Hunt, P.J.1
Yandle, T.G.2
Nicholls, M.G.3
-
7
-
-
0026045343
-
C-type natriuretic peptide (CNP) in rats and humans
-
Komatsu Y, Nakao K, Suga S, et al. C-type natriuretic peptide (CNP) in rats and humans. Endocrinology. 1991;129:1104-1106.
-
(1991)
Endocrinology
, vol.129
, pp. 1104-1106
-
-
Komatsu, Y.1
Nakao, K.2
Suga, S.3
-
8
-
-
0032430953
-
C-Type natriuretic peptide: The endothelial component of the natriuretic peptide system
-
Chen H, Burnett J. C-Type natriuretic peptide: The endothelial component of the natriuretic peptide system. J Cardiovasc Pharmacol. 1998;32:S22-S28.
-
(1998)
J Cardiovasc Pharmacol
, vol.32
-
-
Chen, H.1
Burnett, J.2
-
9
-
-
0025182613
-
N-terminally extended form of C-type natriuretic peptide (CNP-53) identified in porcine brain
-
Minamino N, Kangawa K, Matsuo H. N-terminally extended form of C-type natriuretic peptide (CNP-53) identified in porcine brain. Biochem Biophys Res Commun. 1990;170:973-979.
-
(1990)
Biochem Biophys Res Commun
, vol.170
, pp. 973-979
-
-
Minamino, N.1
Kangawa, K.2
Matsuo, H.3
-
10
-
-
0025781646
-
Gene and precursor structures of human C-type natriuretic peptide
-
Tawaragi Y, Fuchimura K, Tanaka S, et al. Gene and precursor structures of human C-type natriuretic peptide. Biochem Biophys Res Commun. 1991;175:645-651.
-
(1991)
Biochem Biophys Res Commun
, vol.175
, pp. 645-651
-
-
Tawaragi, Y.1
Fuchimura, K.2
Tanaka, S.3
-
11
-
-
0031589516
-
Increased renal natriuretic peptide (urodilatin) excretion in heart failure patients
-
Drummer C, Kentsch M, Otter W, et al. Increased renal natriuretic peptide (urodilatin) excretion in heart failure patients. Eur J Med Res. 1997;2:347-354.
-
(1997)
Eur J Med Res
, vol.2
, pp. 347-354
-
-
Drummer, C.1
Kentsch, M.2
Otter, W.3
-
12
-
-
0026722911
-
Molecular biology of the natriuretic peptides and their receptors
-
Koller K, Goeddel D. Molecular biology of the natriuretic peptides and their receptors. Circulation. 1992;86:1081-1088.
-
(1992)
Circulation
, vol.86
, pp. 1081-1088
-
-
Koller, K.1
Goeddel, D.2
-
13
-
-
0025610718
-
Cellular mechanisms of the clearance function of Type C receptors of atrial natriuretic factor
-
Nussenzveig D, Lewicki J, Maack T. Cellular mechanisms of the clearance function of Type C receptors of atrial natriuretic factor. J Biol Chem. 1990;265:20952-20958.
-
(1990)
J Biol Chem
, vol.265
, pp. 20952-20958
-
-
Nussenzveig, D.1
Lewicki, J.2
Maack, T.3
-
14
-
-
0023891812
-
Atrial natriuretic peptide clearance receptor
-
Fuller F, Porter JG, Arfsten AE, et al. Atrial natriuretic peptide clearance receptor. J Biol Chem. 1988;263:9395-9401.
-
(1988)
J Biol Chem
, vol.263
, pp. 9395-9401
-
-
Fuller, F.1
Porter, J.G.2
Arfsten, A.E.3
-
15
-
-
0031970301
-
Atrial natriuretic peptide release is more dependent on atrial filling volume than on filling pressure in chronic congestive heart failure
-
Globits S, Frank H, Pacher B, et al. Atrial natriuretic peptide release is more dependent on atrial filling volume than on filling pressure in chronic congestive heart failure. Am Heart J. 1998;135:592-597.
-
(1998)
Am Heart J
, vol.135
, pp. 592-597
-
-
Globits, S.1
Frank, H.2
Pacher, B.3
-
16
-
-
0023874660
-
Atrial stretch, not pressure, is the principle determinant controlling the acute release of atrial natriuretic factor
-
Edwards B, Zimmerman R, Schwab T, et al. Atrial stretch, not pressure, is the principle determinant controlling the acute release of atrial natriuretic factor. Circ Res. 1988;62:191-195.
-
(1988)
Circ Res
, vol.62
, pp. 191-195
-
-
Edwards, B.1
Zimmerman, R.2
Schwab, T.3
-
17
-
-
0031862908
-
Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction
-
Maeda K, Tsutamoto T, Wada A, Hisanaga T, Kinoshita M. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J. 1998;135:825-832.
-
(1998)
Am Heart J
, vol.135
, pp. 825-832
-
-
Maeda, K.1
Tsutamoto, T.2
Wada, A.3
Hisanaga, T.4
Kinoshita, M.5
-
18
-
-
0027400105
-
Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with CHF
-
Yoshimura M, Yassue H, Okumura K, et al. Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with CHF. Circulation. 1993;87:464-469.
-
(1993)
Circulation
, vol.87
, pp. 464-469
-
-
Yoshimura, M.1
Yassue, H.2
Okumura, K.3
-
19
-
-
0025729993
-
Brain natriuretic peptide as a novel cardiac hormone in humans
-
Mukoyama M, Nakao K, Hosoda K, et al. Brain natriuretic peptide as a novel cardiac hormone in humans. J Clin Invest. 1991;87:1402-1412.
-
(1991)
J Clin Invest
, vol.87
, pp. 1402-1412
-
-
Mukoyama, M.1
Nakao, K.2
Hosoda, K.3
-
20
-
-
0028900024
-
Atrial and brain natriuretic peptides stimulate the production and secretion of C-type natriuretic peptide from bovine aortic endothelial cells
-
Nazario B, Hu R, Pedram A, et al. Atrial and brain natriuretic peptides stimulate the production and secretion of C-type natriuretic peptide from bovine aortic endothelial cells. J Clin Invest. 1995;95:1151-1157.
-
(1995)
J Clin Invest
, vol.95
, pp. 1151-1157
-
-
Nazario, B.1
Hu, R.2
Pedram, A.3
-
21
-
-
0026703056
-
Endothelial production of C-Type natriuretic peptide and its marked augmentation by Transforming Growth Factor-B
-
Suga S-I, Nakao K, Itoh H, et al. Endothelial production of C-Type natriuretic peptide and its marked augmentation by Transforming Growth Factor-B. J Clin Invest. 1992;90:1145-1149.
-
(1992)
J Clin Invest
, vol.90
, pp. 1145-1149
-
-
Suga, S.-I.1
Nakao, K.2
Itoh, H.3
-
22
-
-
0027142898
-
Cytokine-induced C-Type natriuretic peptide (CNP) secretion from vascular endothelial cells-Evidence for CNP as a novel autocrine/paracrine regulator from endothelial cells
-
Suga S-I, Itoh H, Komatsu Y, et al. Cytokine-induced C-Type natriuretic peptide (CNP) secretion from vascular endothelial cells-Evidence for CNP as a novel autocrine/paracrine regulator from endothelial cells. Endocrinology. 1993;133:3038-3041.
-
(1993)
Endocrinology
, vol.133
, pp. 3038-3041
-
-
Suga, S.-I.1
Itoh, H.2
Komatsu, Y.3
-
23
-
-
0028070631
-
Three peptides from the atrial natriuretic factor prohormone lower blood pressure and produce diuresis, natriuresis, and/or kaliuresis in humans
-
Vesely DL, Douglas MA, Dietz JR, et al. Three peptides from the atrial natriuretic factor prohormone lower blood pressure and produce diuresis, natriuresis, and/or kaliuresis in humans. Circulation. 1994;90:1129-1140.
-
(1994)
Circulation
, vol.90
, pp. 1129-1140
-
-
Vesely, D.L.1
Douglas, M.A.2
Dietz, J.R.3
-
24
-
-
0025347748
-
Three peptides from the ANF prohormone NH2-terminus are natriuretic and/or kaliuretic
-
Martin DR, Pevahouse JB, Trigg DJ, et al. Three peptides from the ANF prohormone NH2-terminus are natriuretic and/or kaliuretic. Am J Physiol. 1990;258:F1401-F1408.
-
(1990)
Am J Physiol
, vol.258
-
-
Martin, D.R.1
Pevahouse, J.B.2
Trigg, D.J.3
-
25
-
-
0024342425
-
Prostaglandin E2 inhibits Na-K-ATPase activity in the inner medullary collecting duct
-
Jabs K, Zeidel M, Silva P. Prostaglandin E2 inhibits Na-K-ATPase activity in the inner medullary collecting duct. Am J Physiol. 1989;257: F424-F430.
-
(1989)
Am J Physiol
, vol.257
-
-
Jabs, K.1
Zeidel, M.2
Silva, P.3
-
26
-
-
0026681801
-
Atrial natriuretic peptide (31-67) inhibits Na transport in rabbit inner medullary collecting duct cells: Role of prostaglandin E2
-
Gunning ME, Brady HR, Otuechere G, et al. Atrial natriuretic peptide (31-67) inhibits Na transport in rabbit inner medullary collecting duct cells: role of prostaglandin E2. J Clin Invest. 1992;89:1411-1417.
-
(1992)
J Clin Invest
, vol.89
, pp. 1411-1417
-
-
Gunning, M.E.1
Brady, H.R.2
Otuechere, G.3
-
27
-
-
0023094428
-
Human prepro atrial natriuretic factors 26-55, 56-92, and 104-123 increase renal guanylate cyclase activity
-
Vesely DL, Bayliss JM, Sallman AL. Human prepro atrial natriuretic factors 26-55, 56-92, and 104-123 increase renal guanylate cyclase activity. Biochem Biophys Res Commun. 1987;143:186-193.
-
(1987)
Biochem Biophys Res Commun
, vol.143
, pp. 186-193
-
-
Vesely, D.L.1
Bayliss, J.M.2
Sallman, A.L.3
-
28
-
-
0025934243
-
Dual effect of cyclic GMP on renal brush border Na-H antiporter
-
Green M, Ruiz OS, Kear F, et al. Dual effect of cyclic GMP on renal brush border Na-H antiporter. Proc Soc Exp Biol Med. 1991;198:846-851.
-
(1991)
Proc Soc Exp Biol Med
, vol.198
, pp. 846-851
-
-
Green, M.1
Ruiz, O.S.2
Kear, F.3
-
29
-
-
0023707301
-
Atrial natriuretic peptide and furosemide effects on hydraulic pressure in the renal papilla
-
Mendez RE, Dunn R, Troy JL, et al. Atrial natriuretic peptide and furosemide effects on hydraulic pressure in the renal papilla. Kidney Int. 1988;34:36-42.
-
(1988)
Kidney Int
, vol.34
, pp. 36-42
-
-
Mendez, R.E.1
Dunn, R.2
Troy, J.L.3
-
30
-
-
0022448027
-
Atrial natriuretic factor inhibits sodium transport in medullary collecting duct
-
Sonnenberg H, Honrath U, Chong CK, et al. Atrial natriuretic factor inhibits sodium transport in medullary collecting duct. Am J Physiol. 1986;250:F963-F966.
-
(1986)
Am J Physiol
, vol.250
-
-
Sonnenberg, H.1
Honrath, U.2
Chong, C.K.3
-
31
-
-
0025668402
-
Effect of pro atrial natriuretic peptides 1-30, 31-67, and 99-126 on angiotensin II-stimulated aldosterone production in calf adrenal cells
-
Denker PS, Vesely DL, Gomez-Sanchez CE. Effect of pro atrial natriuretic peptides 1-30, 31-67, and 99-126 on angiotensin II-stimulated aldosterone production in calf adrenal cells. J Ster Biochem. 1990;37:617-619.
-
(1990)
J Ster Biochem
, vol.37
, pp. 617-619
-
-
Denker, P.S.1
Vesely, D.L.2
Gomez-Sanchez, C.E.3
-
32
-
-
0024432249
-
The N-terminus and a 4000-MW peptide from the midportion of the N-terminus of the atrial natriuretic factor prohormone each circulate in humans and increase in congestive heart failure
-
Winters CJ, Sallman AL, Baker BJ, et al. The N-terminus and a 4000-MW peptide from the midportion of the N-terminus of the atrial natriuretic factor prohormone each circulate in humans and increase in congestive heart failure. Circulation. 1989;80:438-449.
-
(1989)
Circulation
, vol.80
, pp. 438-449
-
-
Winters, C.J.1
Sallman, A.L.2
Baker, B.J.3
-
33
-
-
0026523331
-
Pharmacokinetic characterization of the postdistribution phase of prohormone atrial natriuretic peptides amino acids 1-98, 31-67, and atrial natriuretic factor during and after rapid right ventricular pacing in dogs
-
Ackerman BH, Wyeth RP, Vesely DL, et al. Pharmacokinetic characterization of the postdistribution phase of prohormone atrial natriuretic peptides amino acids 1-98, 31-67, and atrial natriuretic factor during and after rapid right ventricular pacing in dogs. J Clin Pharmacol. 1992;32:415-421.
-
(1992)
J Clin Pharmacol
, vol.32
, pp. 415-421
-
-
Ackerman, B.H.1
Wyeth, R.P.2
Vesely, D.L.3
-
34
-
-
0025651791
-
Biological characterization of human brain natriuretic peptide (BNP) and rat BNP: Species-specific actions of BNP
-
Kambayashi Y, Nakao K, Kimura H, et al. Biological characterization of human brain natriuretic peptide (BNP) and rat BNP: species-specific actions of BNP. Biochem Biophys Res Commun. 1990;173:599-605.
-
(1990)
Biochem Biophys Res Commun
, vol.173
, pp. 599-605
-
-
Kambayashi, Y.1
Nakao, K.2
Kimura, H.3
-
35
-
-
0029798286
-
Differing biological effects of equimolar atrial and brain natriuretic peptide infusions in normal man
-
Hunt PJ, Espiner EA, Nicholls MG, et al. Differing biological effects of equimolar atrial and brain natriuretic peptide infusions in normal man. J Clin Endocrinol Metab. 1996;81:3871-3876.
-
(1996)
J Clin Endocrinol Metab
, vol.81
, pp. 3871-3876
-
-
Hunt, P.J.1
Espiner, E.A.2
Nicholls, M.G.3
-
36
-
-
0025748703
-
Guanylyl cyclases, a growing family of signal-transducing enzymes
-
Koesling D, Bohme E, Schultz G. Guanylyl cyclases, a growing family of signal-transducing enzymes. FASEB J. 1991;5:2785-2791.
-
(1991)
FASEB J
, vol.5
, pp. 2785-2791
-
-
Koesling, D.1
Bohme, E.2
Schultz, G.3
-
38
-
-
0027511651
-
Action of C-type natriuretic peptide in isolated canine arteries and veins
-
Wei C, Aarhus LL, Miller VM, Burnett JC. Action of C-type natriuretic peptide in isolated canine arteries and veins. Am J Physiol. 1993;262: H71-H73.
-
(1993)
Am J Physiol
, vol.262
-
-
Wei, C.1
Aarhus, L.L.2
Miller, V.M.3
Burnett, J.C.4
-
39
-
-
0026535592
-
Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide and C-type natriuretic peptide
-
Suga S, Nakao K, Hosoda K, et al. Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide and C-type natriuretic peptide. Endocrinology. 1992;130:229-239.
-
(1992)
Endocrinology
, vol.130
, pp. 229-239
-
-
Suga, S.1
Nakao, K.2
Hosoda, K.3
-
40
-
-
0025851478
-
C-type natriuretic peptide is a growth inhibitor of rat vascular smooth muscle cells
-
Furuya M, Yoshida M, Minamino N, et al. C-type natriuretic peptide is a growth inhibitor of rat vascular smooth muscle cells. Biochem Biophys Res Commun. 1991;177:927-931.
-
(1991)
Biochem Biophys Res Commun
, vol.177
, pp. 927-931
-
-
Furuya, M.1
Yoshida, M.2
Minamino, N.3
-
42
-
-
0025610718
-
Cellular mechanisms of the clearance function of type C receptors of atrial natriuretic factor
-
Nussenzveig DR, Lewicki JA, Maack T. Cellular mechanisms of the clearance function of type C receptors of atrial natriuretic factor. J Biol Chem. 1990;265:20952-20958.
-
(1990)
J Biol Chem
, vol.265
, pp. 20952-20958
-
-
Nussenzveig, D.R.1
Lewicki, J.A.2
Maack, T.3
-
43
-
-
0030709301
-
Clearance receptors and endopeptidase: Equal role in natriuretic peptide metabolism in heart failure
-
Rademaker MT, Charles CJ, Kosoglou T, et al. Clearance receptors and endopeptidase: equal role in natriuretic peptide metabolism in heart failure. Am J Physiol. 1997;273(5Pt2):H2372-H2379.
-
(1997)
Am J Physiol
, vol.273
, Issue.5 PART 2
-
-
Rademaker, M.T.1
Charles, C.J.2
Kosoglou, T.3
-
44
-
-
0029791110
-
Clearance receptors and endopeptidase 24. 11: Equal role in natriuretic peptide metabolism in conscious sheep
-
Charles CJ, Espiner EA, Nicholls MG, et al. Clearance receptors and endopeptidase 24. 11: equal role in natriuretic peptide metabolism in conscious sheep. Am J Physiol 1996;271:R373-R380.
-
(1996)
Am J Physiol
, vol.271
-
-
Charles, C.J.1
Espiner, E.A.2
Nicholls, M.G.3
-
45
-
-
0027526508
-
Characterization of neutral endo-peptidase in vascular smooth muscle cells of rabbit renal cortex
-
Dussaule JC, Stefanski A, Bea ML, et al. Characterization of neutral endo-peptidase in vascular smooth muscle cells of rabbit renal cortex. Am J Physiol. 1993;264:F45-F52.
-
(1993)
Am J Physiol
, vol.264
-
-
Dussaule, J.C.1
Stefanski, A.2
Bea, M.L.3
-
47
-
-
0022471069
-
Atrial natriuretic peptide elevation in congestive heart failure in the human
-
Burnett JC, Kao PC, DC HU, et al. Atrial natriuretic peptide elevation in congestive heart failure in the human. Science. 1986;231:1145-1147.
-
(1986)
Science
, vol.231
, pp. 1145-1147
-
-
Burnett, J.C.1
Kao, P.C.2
Dc, H.U.3
-
48
-
-
0027162016
-
Natriuretic peptide system in human heart failure
-
Wei C, Heublein DM, Perrella MA, et al. Natriuretic peptide system in human heart failure. Circulation. 1993;88:1004-1009.
-
(1993)
Circulation
, vol.88
, pp. 1004-1009
-
-
Wei, C.1
Heublein, D.M.2
Perrella, M.A.3
-
49
-
-
0023023302
-
Atrial natriuretic factor in normal subjects and heart failure patients
-
Cody RJ, Atlas SA, Laragh JH, et al. Atrial natriuretic factor in normal subjects and heart failure patients. J Clin Invest. 1986;78:1362-1374.
-
(1986)
J Clin Invest
, vol.78
, pp. 1362-1374
-
-
Cody, R.J.1
Atlas, S.A.2
Laragh, J.H.3
-
50
-
-
0023907048
-
Identification of atrial natriuretic factor within ventricular tissue in hamsters and humans with congestive heart failure
-
Edwards BS, Ackermann DM, Lee ME, et al. Identification of atrial natriuretic factor within ventricular tissue in hamsters and humans with congestive heart failure. J Clin Invest. 1988;81:82-86.
-
(1988)
J Clin Invest
, vol.81
, pp. 82-86
-
-
Edwards, B.S.1
Ackermann, D.M.2
Lee, M.E.3
-
51
-
-
0025912123
-
Attenuated renal excretory response to atrial natriuretic peptide in congestive heart failure in man
-
Eiskjaer H, Bagger JP, Danielsen H, et al. Attenuated renal excretory response to atrial natriuretic peptide in congestive heart failure in man. Int J Cardiol. 1991;33:61-74.
-
(1991)
Int J Cardiol
, vol.33
, pp. 61-74
-
-
Eiskjaer, H.1
Bagger, J.P.2
Danielsen, H.3
-
52
-
-
0024583146
-
Decreased atrial natriuretic factor receptors and impaired cGMP generation in glomeruli form the cardiomyopathic hamster
-
Levin ER, Frank HJL, Chaudhari A, et al. Decreased atrial natriuretic factor receptors and impaired cGMP generation in glomeruli form the cardiomyopathic hamster. Biochem Biophys Res Commun. 1989;159:807-814.
-
(1989)
Biochem Biophys Res Commun
, vol.159
, pp. 807-814
-
-
Levin, E.R.1
Frank, H.J.L.2
Chaudhari, A.3
-
53
-
-
0032944045
-
Renal effects of brain natriuretic peptide in patients with congestive heart failure
-
Jensen KT, Carstens J, Pedersen EB. Renal effects of brain natriuretic peptide in patients with congestive heart failure. Clinical Science. 1999;96:5-15.
-
(1999)
Clinical Science
, vol.96
, pp. 5-15
-
-
Jensen, K.T.1
Carstens, J.2
Pedersen, E.B.3
-
54
-
-
0025324969
-
Cardiorenal actions of neutral endopeptidase inhibition in experimental congestive heart failure
-
Cavero PG, Margulies KB, Winaver J, et al. Cardiorenal actions of neutral endopeptidase inhibition in experimental congestive heart failure. Circulation. 1990;82:196-201.
-
(1990)
Circulation
, vol.82
, pp. 196-201
-
-
Cavero, P.G.1
Margulies, K.B.2
Winaver, J.3
-
55
-
-
0025284378
-
Attenuated forearm vasodilative response to atrial natriuretic peptide in patients with heart failure
-
Hirooka Y, Takeshita A, lmaizumi T, et al. Attenuated forearm vasodilative response to atrial natriuretic peptide in patients with heart failure. Circulation. 1990;82:147-153.
-
(1990)
Circulation
, vol.82
, pp. 147-153
-
-
Hirooka, Y.1
Takeshita, A.2
Lmaizumi, T.3
-
56
-
-
0028108589
-
Vasodilatory effects of c-Type natriuretic peptide on forearm resistance vessels are distinct from those of atrial natriuretic peptide in chronic heart failure
-
Nakamura M, Arakawa N, Yoshida H, et al. Vasodilatory effects of c-Type natriuretic peptide on forearm resistance vessels are distinct from those of atrial natriuretic peptide in chronic heart failure. Circulation. 1994;90:1210-1214.
-
(1994)
Circulation
, vol.90
, pp. 1210-1214
-
-
Nakamura, M.1
Arakawa, N.2
Yoshida, H.3
-
57
-
-
0023275885
-
Effect ofreduction in renal artery pressure on atrial natriuretic peptide induced natriuresis
-
Davis CL, Briggs JP. Effect ofreduction in renal artery pressure on atrial natriuretic peptide induced natriuresis. Am J Physiol. 1987;252: F146-F153.
-
(1987)
Am J Physiol
, vol.252
-
-
Davis, C.L.1
Briggs, J.P.2
-
58
-
-
0024438327
-
Restoration of renal response to atrial natriuretic factor in experimental low-output heart failure
-
Redfield MM, Edwards BS, Heublein DM, Burnett JC. Restoration of renal response to atrial natriuretic factor in experimental low-output heart failure. Am J Physiol. 1989;257:R917-R923.
-
(1989)
Am J Physiol
, vol.257
-
-
Redfield, M.M.1
Edwards, B.S.2
Heublein, D.M.3
Burnett, J.C.4
-
59
-
-
0029988221
-
Blunted cGMP response to agonists and enhanced glomerular cyclic 3′5′-nucleotide phosphodiesterase activities in experimental congestive heart failure
-
Supaporn T, Sandberg SM, Borgeson DD, et al. Blunted cGMP response to agonists and enhanced glomerular cyclic 3′5′-nucleotide phosphodiesterase activities in experimental congestive heart failure. Kidnev Int. 1996;50:1718-1725.
-
(1996)
Kidnev Int
, vol.50
, pp. 1718-1725
-
-
Supaporn, T.1
Sandberg, S.M.2
Borgeson, D.D.3
-
60
-
-
0030882421
-
Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population
-
McDonagh TA, Morrison CE, Lawrence A, et al. Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population. Lancet. 1997;350:829-833.
-
(1997)
Lancet
, vol.350
, pp. 829-833
-
-
McDonagh, T.A.1
Morrison, C.E.2
Lawrence, A.3
-
61
-
-
15444361735
-
Circulating levels of cardiac natriuretic peptides (ANP and BNP) measured by highly sensitive and specific immunoradiometric assays in normal subjects and in patients with different degrees of heart failure
-
Clerico A, Lervasi G, Del Chicca MG, et al. Circulating levels of cardiac natriuretic peptides (ANP and BNP) measured by highly sensitive and specific immunoradiometric assays in normal subjects and in patients with different degrees of heart failure. J Endocrinol Invest. 1998;21:170-179.
-
(1998)
J Endocrinol Invest
, vol.21
, pp. 170-179
-
-
Clerico, A.1
Lervasi, G.2
Del Chicca, M.G.3
-
62
-
-
0032477567
-
Biochemical detection of left-ventricular systolic dysfunction
-
McDonagh TA, Robb SD, Murdoch DR, et al. Biochemical detection of left-ventricular systolic dysfunction. Lancet. 1998;351:9-13.
-
(1998)
Lancet
, vol.351
, pp. 9-13
-
-
McDonagh, T.A.1
Robb, S.D.2
Murdoch, D.R.3
-
63
-
-
0031573250
-
Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care
-
Cowie MR, Struthers AD, Wood DA, et al. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet. 1997;350:1347-1351.
-
(1997)
Lancet
, vol.350
, pp. 1347-1351
-
-
Cowie, M.R.1
Struthers, A.D.2
Wood, D.A.3
-
64
-
-
0028158397
-
Plasma brain natriuretic peptide in assessment of acute dyspnea
-
Davis M, Espiner E, Richards G, et al. Plasma brain natriuretic peptide in assessment of acute dyspnea. Lancet. 1994;343:440-444.
-
(1994)
Lancet
, vol.343
, pp. 440-444
-
-
Davis, M.1
Espiner, E.2
Richards, G.3
-
65
-
-
0037130155
-
Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure
-
Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 2002;347:161-167.
-
(2002)
N Engl J Med
, vol.347
, pp. 161-167
-
-
Maisel, A.S.1
Krishnaswamy, P.2
Nowak, R.M.3
-
66
-
-
0029834931
-
Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy
-
Yamamoto K, Burnett JC, Jougasaki M, et al. Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy. Hypertension. 1996;28:988-994.
-
(1996)
Hypertension
, vol.28
, pp. 988-994
-
-
Yamamoto, K.1
Burnett, J.C.2
Jougasaki, M.3
-
67
-
-
0037022231
-
Utility of B-natriuretic peptide in detecting diastolic dysfunction: Comparison with doppler velocity recordings
-
Lubien E, De Maria A, Krishnaswamy, et al. Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with doppler velocity recordings. Circulation 2002;105:595-601.
-
(2002)
Circulation
, vol.105
, pp. 595-601
-
-
Lubien, E.1
De Maria, A.2
Krishnaswamy3
-
68
-
-
0032736511
-
Titration of vasodilator therapy in chronic heart failure according to plasma brain natriuretic peptide concentration: Randomized comparison of the hemodynamic and neuroendocrine effects of tailored versus empirical therapy
-
Murdoch DR, McDonagh TA, Byrne J, et al. Titration of vasodilator therapy in chronic heart failure according to plasma brain natriuretic peptide concentration: randomized comparison of the hemodynamic and neuroendocrine effects of tailored versus empirical therapy. Am Heart J. 1999;138:1126-1132.
-
(1999)
Am Heart J
, vol.138
, pp. 1126-1132
-
-
Murdoch, D.R.1
McDonagh, T.A.2
Byrne, J.3
-
69
-
-
0030806988
-
Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure
-
Tsutamoto T, Wada A, Maedo K, et al. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure. Circulation. 1997;96:509-516.
-
(1997)
Circulation
, vol.96
, pp. 509-516
-
-
Tsutamoto, T.1
Wada, A.2
Maedo, K.3
-
70
-
-
0030804506
-
Immunoreactive aminoterminal pro-brain natriuretic peptide (NT-PROBNP): A new marker of cardiac impairment
-
Hunt PJ, Richards AM, Nicholls MG, et al. Immunoreactive aminoterminal pro-brain natriuretic peptide (NT-PROBNP): a new marker of cardiac impairment. Clin Endocrinol. 1997;47:287-296.
-
(1997)
Clin Endocrinol
, vol.47
, pp. 287-296
-
-
Hunt, P.J.1
Richards, A.M.2
Nicholls, M.G.3
-
71
-
-
0028788981
-
The amino-terminal portion of pro-brain natriuretic peptide (pro-bnp) circulates in human plasma
-
Hunt PJ, Yandle TG, Nicholls MG, et al. The amino-terminal portion of pro-brain natriuretic peptide (pro-bnp) circulates in human plasma. Biochem Biophys Res Commun. 1995;214:1175-1183.
-
(1995)
Biochem Biophys Res Commun
, vol.214
, pp. 1175-1183
-
-
Hunt, P.J.1
Yandle, T.G.2
Nicholls, M.G.3
-
72
-
-
0032888296
-
Comparison of vessel dilator and long-acting natriuretic peptide in the treatment of congestive heart failure
-
Vesely DL, Dietz JR, Parks JR, et al. Comparison of vessel dilator and long-acting natriuretic peptide in the treatment of congestive heart failure. Am Heart J. 1999;138:625-632.
-
(1999)
Am Heart J
, vol.138
, pp. 625-632
-
-
Vesely, D.L.1
Dietz, J.R.2
Parks, J.R.3
-
73
-
-
0029906914
-
Processing of long-acting natriuretic peptide and vessel dilator in human plasma and serum
-
Overton RM, Vesely DL. Processing of long-acting natriuretic peptide and vessel dilator in human plasma and serum. Peptides. 1996;17:1155-1162.
-
(1996)
Peptides
, vol.17
, pp. 1155-1162
-
-
Overton, R.M.1
Vesely, D.L.2
-
74
-
-
0026050182
-
Hemodynamic, renal, and hormonal responses to brain natriuretic peptide infusion in patients with congestive heart failure
-
Yoshimura M, Yasue H, Morita E, et al. Hemodynamic, renal, and hormonal responses to brain natriuretic peptide infusion in patients with congestive heart failure. Circulation. 1991;84:1581-1588.
-
(1991)
Circulation
, vol.84
, pp. 1581-1588
-
-
Yoshimura, M.1
Yasue, H.2
Morita, E.3
-
75
-
-
0034721244
-
Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure
-
Colucci WS, Elkayam U, Horton DP, et al. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. N Engl J Med. 2000;343:246-253.
-
(2000)
N Engl J Med
, vol.343
, pp. 246-253
-
-
Colucci, W.S.1
Elkayam, U.2
Horton, D.P.3
-
76
-
-
0033165565
-
Sustained hemodynamic effects of an infusion of nesiritide (Human b-type natriuretic peptide) in heart failure
-
Mills RM, LeJemtel TH, Horton DP, et al. Sustained hemodynamic effects of an infusion of nesiritide (Human b-type natriuretic peptide) in heart failure. J Am Coll Cardiol. 1999;34:155-162.
-
(1999)
J Am Coll Cardiol
, vol.34
, pp. 155-162
-
-
Mills, R.M.1
LeJemtel, T.H.2
Horton, D.P.3
-
77
-
-
0035399986
-
Comparison of the occurrence of ventricular arrhythmias in patients with acutely decompensated congestive heart failure receiving dobutamine versus nesiritide therapy
-
Burger AJ, Elkayam U, Neibaur MT, et al. Comparison of the occurrence of ventricular arrhythmias in patients with acutely decompensated congestive heart failure receiving dobutamine versus nesiritide therapy. Am J Cardiol. 2001;88:35-39.
-
(2001)
Am J Cardiol
, vol.88
, pp. 35-39
-
-
Burger, A.J.1
Elkayam, U.2
Neibaur, M.T.3
-
78
-
-
0037181511
-
Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: A randomized controlled trial
-
Young JB, Abraham WT, Stevenson LW, et al. Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial. JAMA. 2002;287:1531-1540.
-
(2002)
JAMA
, vol.287
, pp. 1531-1540
-
-
Young, J.B.1
Abraham, W.T.2
Stevenson, L.W.3
-
79
-
-
0037028855
-
Effect of nesiritide versus dobutamine on short-term outcomes in the treatment of patients with acutely decompensated heart failure
-
Silver MA, Horton DP, Ghali JK, Elkayam U. Effect of nesiritide versus dobutamine on short-term outcomes in the treatment of patients with acutely decompensated heart failure. J Am Coll Cardiol. 2002;39:798-803.
-
(2002)
J Am Coll Cardiol
, vol.39
, pp. 798-803
-
-
Silver, M.A.1
Horton, D.P.2
Ghali, J.K.3
Elkayam, U.4
-
80
-
-
0038224823
-
Natriuretic and other vasoactive peptides
-
Frishman WH, Sonnenblick EH, Sica DA (eds). New York: McGraw Hill
-
Frishman WH, Sica DA, Cheng JWM, et al. Natriuretic and other vasoactive peptides. In Frishman WH, Sonnenblick EH, Sica DA (eds): Cardiovascular Pharmacotherapeutics. 2nd ed. New York: McGraw Hill 2003:451-477.
-
(2003)
Cardiovascular Pharmacotherapeutics. 2nd Ed.
, pp. 451-477
-
-
Frishman, W.H.1
Sica, D.A.2
Cheng, J.W.M.3
-
81
-
-
0029619616
-
Cardiovascular effects of the novel dual inhibitor of neutral endopeptidase and angiotensin-converting enzyme BMS-182657 in experimental hypertension and heart failure
-
Trippodo NC, Robl JA, Asaad MM, et al. Cardiovascular effects of the novel dual inhibitor of neutral endopeptidase and angiotensin-converting enzyme BMS-182657 in experimental hypertension and heart failure. J Pharmacol Exp Ther. 1995;275:745-752.
-
(1995)
J Pharmacol Exp Ther
, vol.275
, pp. 745-752
-
-
Trippodo, N.C.1
Robl, J.A.2
Asaad, M.M.3
-
82
-
-
0025719871
-
Angiotensin inhibition potentiates the renal responses to neutral endopeptidase inhibition in dogs with congestive heart failure
-
Margulies KB, Perrella MA, McKinley LJ, Burnett JC. Angiotensin inhibition potentiates the renal responses to neutral endopeptidase inhibition in dogs with congestive heart failure. J Clin Invest. 1991;88:1636-1642.
-
(1991)
J Clin Invest
, vol.88
, pp. 1636-1642
-
-
Margulies, K.B.1
Perrella, M.A.2
McKinley, L.J.3
Burnett, J.C.4
-
83
-
-
0031693940
-
Chronic dual inhibition of angiotensin-converting enzyme and neutral endopeptidase during the development of left ventricular dysfunction in dogs
-
Thomas CV, McDaniel GM, Holzgrefe HH, et al. Chronic dual inhibition of angiotensin-converting enzyme and neutral endopeptidase during the development of left ventricular dysfunction in dogs. J Cardiovasc Pharmacol. 1998;32:902-912.
-
(1998)
J Cardiovasc Pharmacol
, vol.32
, pp. 902-912
-
-
Thomas, C.V.1
McDaniel, G.M.2
Holzgrefe, H.H.3
-
84
-
-
0031975483
-
Combined neutral endopeptidase and angiotensin-converting enzyme inhibition in heart failure: Role of natriuretic peptides and angiotensin II
-
Rademaker MT, Charles CJ, Espiner EA, et al. Combined neutral endopeptidase and angiotensin-converting enzyme inhibition in heart failure: role of natriuretic peptides and angiotensin II. J Cardiovasc Pharmacol. 1998;31:116-125.
-
(1998)
J Cardiovasc Pharmacol
, vol.31
, pp. 116-125
-
-
Rademaker, M.T.1
Charles, C.J.2
Espiner, E.A.3
-
85
-
-
0031955506
-
Effects of omapatrilat in low, normal, and high renin experimental hypertension
-
Trippodo NC, Robl JA, Asaad MM, et al. Effects of omapatrilat in low, normal, and high renin experimental hypertension. Am J Hypertens. 1998;11:363-372.
-
(1998)
Am J Hypertens
, vol.11
, pp. 363-372
-
-
Trippodo, N.C.1
Robl, J.A.2
Asaad, M.M.3
-
86
-
-
0003068899
-
Steady-state pharmacokinetics and pharmacodynamics of omapatrilat in normotensive subjects
-
Liao W, Vesterqvist O, Delaney CL, et al. Steady-state pharmacokinetics and pharmacodynamics of omapatrilat in normotensive subjects [abstract]. J Hypertens. 1996;17(Suppl 3):S66.
-
(1996)
J Hypertens
, vol.17
, Issue.SUPPL. 3
-
-
Liao, W.1
Vesterqvist, O.2
Delaney, C.L.3
-
87
-
-
0035885017
-
Effects of omapatrilat on hemodynamics and safety in patients with heart failure
-
Klapholz M, Thomas I, Eng C, et al. Effects of omapatrilat on hemodynamics and safety in patients with heart failure. Am J Cardiol. 2001;88:657-661.
-
(2001)
Am J Cardiol
, vol.88
, pp. 657-661
-
-
Klapholz, M.1
Thomas, I.2
Eng, C.3
-
88
-
-
0033862042
-
The clinical, cardiac, renal, arterial and neurohormonal effects of omapatrilat, a vasopeptidase inhibitor, in patients with chronic heart failure
-
McClean DR, Ikram H, Garlick AH, et al. The clinical, cardiac, renal, arterial and neurohormonal effects of omapatrilat, a vasopeptidase inhibitor, in patients with chronic heart failure. J Am Coll Cardiol. 2000;36:479-486.
-
(2000)
J Am Coll Cardiol
, vol.36
, pp. 479-486
-
-
McClean, D.R.1
Ikram, H.2
Garlick, A.H.3
-
89
-
-
0034686963
-
Comparison ofvasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trial
-
Rouleau JL, Pfeffer MA, Stewart DJ, et al. Comparison ofvasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trial. Lancet. 2000;356:615-620.
-
(2000)
Lancet
, vol.356
, pp. 615-620
-
-
Rouleau, J.L.1
Pfeffer, M.A.2
Stewart, D.J.3
-
90
-
-
0038563473
-
Omapatrilat versus enalapril randomized trial of utility in reducing events (OVERTURE)
-
Packer M. Omapatrilat versus enalapril randomized trial of utility in reducing events (OVERTURE). J Am Coll Cardiol. 2002;40:17-18.
-
(2002)
J Am Coll Cardiol
, vol.40
, pp. 17-18
-
-
Packer, M.1
-
91
-
-
0037887285
-
Omapatrilat cardiovascular treatment assessment versus enalapril (OCTAVE)
-
June 23-27, Prague, Czech Republic
-
th European Meeting on Hypertension, June 23-27, 2002, Prague, Czech Republic.
-
(2002)
th European Meeting on Hypertension
-
-
Kostis, J.B.1
-
92
-
-
0036082757
-
Nesiritide: Review of clinical pharmacology and role in heart failure management
-
Cheng JWM. Nesiritide: review of clinical pharmacology and role in heart failure management. Heart Dis. 2002;4:199-203.
-
(2002)
Heart Dis
, vol.4
, pp. 199-203
-
-
Cheng, J.W.M.1
|